Immunosuppressive microenvironment improvement and treatment of aggressive malignancy pancreatic ductal adenocarcinoma based on local administration of injectable hydrogel

Nano Today - Tập 50 - Trang 101832 - 2023
Wenjia Zhang1, Shukun Li2, Yamei Liu2, Ruirui Xing2, Zhengyu Jin1, Xuehai Yan2,3, Huadan Xue1
1Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
2State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, China
3School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing 100049, China

Tài liệu tham khảo

Siegel, 2022, CA Cancer J. Clin., 72, 7, 10.3322/caac.21708 Willett, 2005, J. Clin. Oncol., 23, 4538, 10.1200/JCO.2005.23.911 Zeng, 2019, Int J. Mol. Sci., 20 Mizrahi, 2020, Lancet, 2008-2020, 395 Collisson, 2011, Nat. Med, 17, 500, 10.1038/nm.2344 Stathis, 2010, Nat. Rev. Clin. Oncol., 7, 163, 10.1038/nrclinonc.2009.236 Binnewies, 2018, Nat. Med, 24, 541, 10.1038/s41591-018-0014-x Quail, 2013, Nat. Med, 19, 1423, 10.1038/nm.3394 Ho, 2020, Nat. Rev. Clin. Oncol., 17, 527, 10.1038/s41571-020-0363-5 Scheper, 2019, Nat. Med, 25, 89, 10.1038/s41591-018-0266-5 Zhao, 2020, Angew. Chem. Int Ed. Engl., 59, 3793, 10.1002/anie.201909825 Li, 2021, Adv. Mater., 33 Li, 2020, Chem. Sci., 11, 8644, 10.1039/D0SC02937H Liu, 2019, Chem. Soc. Rev., 48, 2053, 10.1039/C8CS00618K Xing, 2017, Biomacromolecules, 18, 3514, 10.1021/acs.biomac.7b00787 Melero, 2021, Nat. Rev. Clin. Oncol., 18, 558, 10.1038/s41571-021-00507-y Ahmed, 2014, A. International Working Group on Image-guided Tumor, P. Interventional Oncology Sans Frontieres Expert, R. Technology Assessment Committee of the Society of Interventional, C. Standard of Practice Committee of the, E., Interv. Radiol. Soc. , Radiol., 273, 241 Bazan-Peregrino, 2021, Cancer, 9 Pang, 2021, J. Hematol. Oncol., 14, 118, 10.1186/s13045-021-01128-9 Tan, 2017, Int Immunopharmacol., 47, 88, 10.1016/j.intimp.2017.03.025 Xing, 2019, Adv. Mater., 31, 10.1002/adma.201900822 Loktev, 2018, J. Nucl. Med, 59, 1423, 10.2967/jnumed.118.210435 Norouzi, 2016, Drug Disco Today, 21, 1835, 10.1016/j.drudis.2016.07.006 Xing, 2016, Adv. Mater., 28, 3669, 10.1002/adma.201600284 Mallya, 1876, Biochim Biophys. Acta Rev. Cancer, 2021 Chu, 2014, Nat. Rev. Cancer, 14, 199, 10.1038/nrc3672 Song, 2019, 13, 7750 Lim, 2011, Adv. Mater., 23, 2436, 10.1002/adma.201100351 Ahn, 2018, Surg. Oncol., 27, 61, 10.1016/j.suronc.2017.11.008 Mansurov, 2020, Nat. Biomed. Eng., 4, 531, 10.1038/s41551-020-0549-2 Brahmer, 2012, 366, 2455 Royal, 2010, 33, 828 Wang, 2022, Acta Biomater., 138, 453, 10.1016/j.actbio.2021.10.048 Zhao, 2022, Adv. Mater., 34 Chen, 2016, Nat. Commun., 7, 13193, 10.1038/ncomms13193 Riley, 2017, Wiley Inter. Rev. Nanomed. Nanobiotechnol, 9 Chang, 2021, Adv. Mater., 33 Ryan, 2014, 371, 1039 Lee, 2010, Int J. Hyperth., 26, 232, 10.3109/02656731003601745 Alves, 2022, Pharmaceutics, 14 Chen, 2019, Adv. Mater., 31